When oncologists greenlight pricey drugs

Australian oncologists will only recommend expensive, unfunded therapies over subsidised drugs if they add at least two months to their patients’ lives, according to Sydney researchers.

They identified the two-month threshold via a discrete choice experiment involving 100 oncologists from the Medical Oncology Group of Australia.

They were given 15 scenarios and asked to choose between two hypothetical drugs based on